Executive Overview
Medicare Part D Intelligence · CY2025
Year:
Class:
Carrier:
🏛 Elite Medicare Analytics · CY2025
The definitive
Part D intelligence
platform.
Formulary friction scoring, IRA impact modeling, claims pattern analysis, and clinical strategy insights — built for analysts, brokers, and health plan executives.
Part D Plans (CY2025)
3,918
↑8.2% vs CY24 enrollment
CMS Plan Finder · 2025
Specialty Drugs w/ PA
94%
↑6pp year-over-year rise
CMS Formulary PUF · CY2025
Part D OOP Cap
$2,100
live in 2026 · rises to $2,400 in 2027
IRA 2022 · CY2027 Advance Notice
Negotiated Drugs (MFP)
25
10 live now · 15 more effective Jan 2027
CMS Drug Negotiation · 2025
Market Signals
High-impact formulary intelligence
Live
Tier Coverage Distribution
Across top 200 Part D drugs
CMS PUF
IRA Savings Preview
Estimated 2026 member benefit
IRA 2022
Most Restricted High-Cost Drugs
By Friction Score (PA + ST + QL + Tier)
CMS Formulary PUF · CY2025
Strategic Notes
This week's consulting insights
Multi-Drug · State · Plan Comparison
Formulary Coverage Search
Search one or more drugs by name, RXCUI, or NDC. Compare Tier, QL, PA, and ST across Medicare Advantage plans by state — with the source and effective date on every row.
Loading formulary data source…
Add as many drugs as you like. Names are pulled live from the NLM RxNorm/RxTerms directory.
Status legend: Confirmed from a CMS file or official plan doc · Inferred filled gap, not official · Representative sample for this demo · Conflict sources disagree · Stale past the refresh window.
Educational use only — verify against official carrier formulary documents before any decision.
Coverage areas: PA, WV, DE, NY, and the Kansas City metro (MO). Note: Blue KC exited Medicare Advantage on 1/1/2025, so it is not a current MA-PD carrier — KC-metro rows show the carriers that do serve that area.
Module 1 · Formulary Friction Matrix
Where carriers resist
drug access — and why.
Friction Score = f(Prior Auth, Step Therapy, Quantity Limits, Tier Placement). Higher scores indicate greater access barriers for members — and higher rebate capture for the carrier.
Friction Score Scale:
2
Low
4
Moderate
6
High
8
Very High
10
Maximum
Average Friction Score by Carrier
Across top 50 specialty drugs
CMS Formulary PUF · Representative · CY2025
Module 2 · Part D Claims & Payment Explorer
From list price to
net cost — the full picture.
Drug Cost Waterfall: List Price → Maximum Fair Price / Negotiated → Estimated Rebate → Plan Net Cost → Member OOP. Overlay geographic prescribing variance by drug class.
Rebate estimates are proxy calculations based on CMS gross/net drug cost ratios and published Medicare rebate benchmarks. Actual rebates are confidential. CMS PUF · Milliman proxy
Drug Cost Waterfall
30-day supply · Medicare Part D member perspective
Geographic Prescribing Variance
Indexed prescribing intensity vs national average (100 = national avg)
Module 3 · IRA $2,100 Cap Impact Simulator
Quantify the real value
of the IRA benefit redesign.
Model how the OOP cap ($2,100 in 2026, $2,400 in 2027) and Maximum Fair Price (MFP) negotiations change net drug spending for Medicare beneficiaries across conditions and drug classes.
Configure Scenario
Select condition, drug, and member profile
Condition / Drug Class
Specific Drug
Member Annual Income
Plan Year Comparison
$0
Estimated annual savings vs CY2024
Annual OOP Comparison
CY2024 → CY2025 → CY2026 (live) → CY2027 (IRA)
IRA Maximum Fair Price — Round 1: 10 Drugs In effect since Jan 2026
Source: CMS Medicare Drug Price Negotiation Program · 30-day list price
CMS · IRA 2022
IRA Maximum Fair Price — Round 2: 15 Drugs Effective Jan 2027
Announced Nov 25, 2025 · adds Ozempic/Wegovy, Trelegy, Xtandi, Ibrance & more · 30-day list price
CMS · IRA 2022
MFP = the price Medicare pays the manufacturer, not the member's out-of-pocket cost. Members are still protected by the annual cap ($2,400 in 2027) regardless of list price. Note: under Nov 2025 "most-favored-nation" deals, Ozempic/Wegovy may carry a $245 Medicare price below the $274 IRA MFP.
Module 4 · Rx Learning Hub
Strategy behind
every data point.
Consulting-grade insights that translate formulary mechanics, carrier strategy, and Part D economics into actionable intelligence for brokers, analysts, and plan executives.
Technical Architecture · PostgreSQL · Python · Next.js App Router
Database Schema & Ingestion Architecture
Production-ready schema for Part D PUF, Formulary PUF, IRA data, and FDA drug data. Python ingestion scripts and Next.js API route structure.
Data Sources · Methodology · Disclaimers
How we source, process,
and present data.